Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-15-025742
Filing Date
2015-06-29
Accepted
2015-06-29 15:30:06
Documents
1
Period of Report
2015-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 7285
  Complete submission text file 0001140361-15-025742.txt   8699
Mailing Address C/O INFINERA CORPORATION 140 CASPIAN COURT SUNNYVALE CA 94089
Business Address
Welch David F (Reporting) CIK: 0001399122 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54495 | Film No.: 15958057

Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Issuer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations